DCF — UCSD MEDICAL CENTER
Enterprise Value: $-3.6B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.6B
Enterprise Value
$-1.2B
PV of Cash Flows
$-2.5B
PV of Terminal Value
$-4.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.2B | $-210.5M | -7.0% | $-344.0M | $-312.7M |
| Year 2 | $3.2B | $-184.3M | -6.0% | $-321.8M | $-266.0M |
| Year 3 | $3.3B | $-156.4M | -5.0% | $-298.0M | $-223.9M |
| Year 4 | $3.4B | $-143.8M | -4.0% | $-289.7M | $-197.9M |
| Year 5 | $3.5B | $-139.3M | -4.0% | $-289.5M | $-179.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.6B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07173431056743132
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5